01.02.2014 Views

Pediatric Allergy & Immunology - UT Southwestern

Pediatric Allergy & Immunology - UT Southwestern

Pediatric Allergy & Immunology - UT Southwestern

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Research Activities<br />

Under Dr. Gruchalla’s direction, the division continues to expand both its clinical and basic science research efforts in<br />

asthma. <strong>UT</strong> <strong>Southwestern</strong> was among 11 institutions selected by the National Institutes of Health to receive $56 million<br />

over five years as part of the Inner City Asthma Consortium (ICAC). The ICAC investigates novel treatments and causes<br />

of asthma in urban children. Ongoing studies include a<br />

prospective, longitudinal evaluation of environmental factors<br />

that influence the development of asthma.<br />

The consortium is administered by the University of Wisconsin-<br />

Madison. In addition to <strong>UT</strong> <strong>Southwestern</strong>, research is being<br />

conducted at:<br />

• Boston University,<br />

• Children’s Memorial Hospital in Chicago,<br />

• Children’s National Medical Center in Washington, D.C.,<br />

• Henry Ford Health System in Detroit,<br />

• National Jewish Health in Denver,<br />

• Johns Hopkins University in Baltimore,<br />

• Mount Sinai School of Medicine in New York,<br />

• St. Louis Children’s Hospital, and<br />

• University of California, San Francisco.<br />

In addition to three current studies, a very important trial funded by this consortium was published in March 2011 in the<br />

New England Journal of Medicine, co-authored by Dr. Gruchalla. The article, “Impact of the Addition of Omalizumab<br />

to Guidelines Based Therapy of Inner-City Asthma: A Randomized Controlled Trial,” found that a new anti-asthma<br />

medication, omalizumab, improved asthma control in the 419 children and young adults studied, nearly eliminated seasonal<br />

exacerbations of asthma, and reduced the need for controller medication when used in concert with NIH-based treatment<br />

guidelines. The study was a multi-institutional one involving <strong>UT</strong> <strong>Southwestern</strong> scientists and eight other academic medical<br />

institutions. In addition to the numerous ICAC clinical studies, ICAC-related basic research collaborations also are ongoing<br />

with <strong>UT</strong> <strong>Southwestern</strong> investigators, Drs. Michelle Gill, David Farrar and Nitin Karandikar.<br />

The Primary Immunodeficiency Program is engaged in both clinical and basic research. In collaboration with the Stem<br />

Cell Transplant at Children’s Medical Center, children with primary immunodeficiency diseases can be transplanted at<br />

our institution and are part of the Primary Immunodeficiency National Transplant Consortium (PIDTC). In terms of basic<br />

research, three areas of interest are as follows:<br />

1. To understand the molecular etiologies that may contribute to clinical heterogeneity in patients with primary<br />

immunodeficiency diseases. We are currently collaborating with Dr. Nicolai van Oers, Associate Professor of<br />

<strong>Immunology</strong>, Microbiology and <strong>Pediatric</strong>s at <strong>UT</strong> <strong>Southwestern</strong>, who has profiled the microRNA expression pattern in<br />

patients with Primary Immunodeficiency Diseases.<br />

2. To understand the long-term natural history of patients with X-linked hyper IgM syndrome. Dr. de la Morena has<br />

received funding through the Jeffrey Modell Foundation for this multinational collaborative study.<br />

3. To identify novel genes in primary immunodeficiency disease through exome sequencing. This project is done in<br />

collaboration with Dr. Ward Wakeland, Professor and Chairman of <strong>Immunology</strong> at <strong>UT</strong> <strong>Southwestern</strong>. The PIDs<br />

continue to provide unique opportunities to further our understanding of the biology of normal human immune<br />

function.<br />

Clinical Activities<br />

Asthma and <strong>Allergy</strong><br />

The Asthma and <strong>Allergy</strong> outpatient clinic is equipped to diagnose and manage the whole spectrum of allergic diseases. There<br />

are nine half day clinics per week to provide care for patients. An average of 200 patients are seen per month for evaluation<br />

and management of various atopic diseases, including, but not limited to, asthma, allergic rhinitis, atopic dermatitis, food<br />

allergy, insect sting allergy and drug allergy. Procedures such as skin prick testing for environmental and food allergens,<br />

hymenoptera venom allergy testing and testing for drug allergies are performed by trained personnel. Other services offered<br />

are immunotherapy - both traditional and rush - and anti-IgE immunoglobulin administration.<br />

2<br />

A Pulmonary Function Lab is available for spirometry as well as exhaled nitric oxide studies for the evaluation and<br />

management of patients with asthma. Providers work closely with educators from the Asthma Education and Asthma<br />

Management programs to provide a comprehensive management strategy for patients with severe asthma. Special procedures<br />

such as drug challenges and food challenges are also performed in the outpatient clinic.<br />

A combined <strong>Allergy</strong>/<strong>Immunology</strong> and Otolaryngology sinus clinic (CASCADE) has been established to provide<br />

comprehensive care for patients with chronic sinusitis. One half-day clinic per month is offered at both the Dallas and<br />

Legacy campus. To facilitate care, patients who are seen in these clinics have a complete evaluation of allergen sensitization<br />

patterns and immunological system, as well as an otolaryngological evauluation in one setting.<br />

A multidisciplinary High Risk asthma clinic was established in the summer of 2011 to provide comprehensive asthma care<br />

to patients with severe asthma and other co-morbid conditions. Two half-day clinics are offered at the Dallas campus where<br />

patients are evaluated by multiple providers including an allergist, pulmonologist, nutritionist, psychologist and asthma<br />

educators to provide comprehensive asthma care and education.<br />

An active inpatient consult service is available for evaluation of patients with allergic diseases. Consults are usually requested<br />

in cases of suspected drug-allergy, anaphylactic reactions and severe asthma.<br />

Food <strong>Allergy</strong><br />

In September of 2010, the Food <strong>Allergy</strong> Center (FAC) at Children’s, which is directed by Dr. Drew Bird, officially opened its<br />

doors. This multidisciplinary center, in association with <strong>UT</strong> <strong>Southwestern</strong>, is the only academically affiliated pediatric food<br />

allergy program in North Texas. As such, the Center provides comprehensive care for patients who have been diagnosed<br />

with food allergies and conducts research that is instrumental in developing treatments, therapies and, ultimately, a cure for<br />

food allergies. Its staff also works tirelessly throughout the region to educate parents, healthcare providers, school personnel<br />

and community stakeholders to help children and families navigate the many challenges associated with this complex<br />

health issue.<br />

In 2011, the FAC continued to expand its influence within North Texas. Highlights from the year include the following:<br />

Clinical Care<br />

• Nearly 1,000 clinic visits were conducted.<br />

• 134 food challenges were performed with assistance from Maria Crain,<br />

PNP. The food challenge process entails giving the child incremental<br />

doses of a particular food over one hour and monitoring the child for an<br />

additional period of time. If the child can tolerate a full serving of the<br />

potentially allergenic food without having an allergic reaction, the food<br />

may be introduced into the child’s diet.<br />

Research<br />

• A total of 12 children are currently enrolled in a peanut oral immunotherapy<br />

trial aimed at understanding how the immune system develops tolerance to<br />

peanut in peanut allergic children receiving therapy.<br />

• Two multi-center trials examining the safety of giving the flu vaccine to a<br />

child with an egg allergy. The influenza vaccine contains a small amount of<br />

egg protein, and, as such, is administered cautiously to children with egg<br />

allergies.<br />

• Investigating changes in the quality of life for families dealing with food<br />

Dr. Drew Bird<br />

Director, Food <strong>Allergy</strong> Center<br />

allergies who attend instructional cooking classes. This study seeks to better understand how cooking classes offered<br />

through our Center by a registered dietitian improve the quality of life for children affected by food allergies.<br />

• More than 100 families have participated in our interactive nut identification quiz. The goal of this study is to provide<br />

insight into the ability of those with tree nut allergies to accurately identify the nuts to which they are allergic, as well<br />

as those to which they are not.<br />

Advocacy and Education<br />

• One of the first overnight camps specifically for children with food allergies was hosted at Camp Sweeney in Gainesville,<br />

Texas. Thirty-five children attended camp where safe meals were prepared avoiding a cumulative total of more than 30<br />

different allergens.<br />

• The second annual Food <strong>Allergy</strong> Collaborative hosted Wesley Burks, M.D., Kiser-Arena Professor and Chief of the<br />

Division of <strong>Pediatric</strong> <strong>Allergy</strong> and <strong>Immunology</strong> at Duke University Medical Center in Durham, North Carolina, and an<br />

3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!